EUCTR2017-005038-53-ES进行中（未招募）1 期
Randomized double-blind, placebo-controlled study evaluate the efficacy and mechanisms involved in immunotherapy Sublingual specifies with Pru p 3 (Pru p 3-ITSL) in patients with allergy to nsLTP with severe symptoms in its response to Peach, peanut, artemisia and olive.
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina Y Salud (FIMABIS)0 个研究点目标入组 99 人开始时间: 2018年11月23日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 99
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •1. Informed Consent (IC) for the study and for the Biobank signed
- •2. Men or women =5 and =55 years of age.
- •3. Moderate/severe allergic reaction after ingestion of peach, with or without peanut, confirmed by PPDCCP with peach.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 33
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 66
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Pregnancy and lactation.
- •2. Immunological diseases, treatments with immunomodulators and/or blockers.
- •3. Mental illness.
- •4. Severe atopic dermatitis according to SCORAD (53)
- •5. FEV1 <70%.
- •6. Inflammation in the oral cavity with severe symptoms, oral surgery in the previous 7 days.
研究者
相似试验
进行中（未招募）
3 期
Medicine to prevent chemotherapy complicatioCTRI/2022/02/040030Dr Atul Batra
进行中（未招募）
3 期
A study of topical diclofenac gel to prevent hand foot syndrome due to capecitabine in breast and gastrointestinal cancersCTRI/2021/01/030592Indian Association of Supportive Care in Cancer
进行中（未招募）
不适用
A clinical study with NEURAPAS® balance or a placebo drug, in addition to psychoeducation or psychotherapy in adolescents from 12 to 17 years suffering from mild depressive episodes with nervous restlessnessMild depressive episodes with nervous restlessnessMedDRA version: 14.1Level: LLTClassification code 10012402Term: Depressive episodeSystem Organ Class: 100000004873EUCTR2012-004627-20-DEPascoe pharmazeutische Präparate GmbH
进行中（未招募）
不适用
Randomised, double-blind, placebo-controlled study to investigate the efficacy and safety of a herbal combination product, Eviprostat N, in the treatment of moderate LUTS associated with benign prostatic hyperplasia” - EVE 2004/01Patients with moderate LUTS (Lower Urinary Tract Symptoms) associated with benign prostatic hyperplasiaMedDRA version: 7.0Level: LLTClassification code 10004446EUCTR2004-002901-57-DEPharmazeutische Fabrik Evers & Co. GmbH326
已完成
不适用
Randomised, double-blind, placebo-controlled study to evaluate the safety, tolerability, immunogenicity and shedding of live-attenuated RSV vaccine in healthy adults<br>NL-OMON47495Intravacc48